Can Coaching Improve GLP-1 Weight Loss Results?

Last reviewed: June 3, 2026

Last updated: June 3, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

There is a randomised trial that speaks to this almost directly. STEP 3 gave every participant intensive behavioral therapy — 30 counselling visits over 68 weeks, plus a low-calorie diet for the first 8 weeks — and randomised them to semaglutide 2.4 mg or placebo. The placebo group, receiving coaching alone, lost a mean of 5.7% of body weight. The semaglutide group lost 16.0%. For comparison, the placebo arm of STEP 1, which received standard lifestyle counselling rather than intensive behavioral therapy, lost 2.4%. Coaching moved the placebo result substantially.

What STEP 3 Actually Tested

STEP 3 was a 68-week, double-blind, randomised trial at 41 U.S. sites in 611 adults without diabetes who had either overweight with at least one comorbidity or obesity. Participants were randomised 2:1 to semaglutide 2.4 mg or placebo, with both arms receiving a low-calorie diet for the first 8 weeks and intensive behavioral therapy throughout.

At week 68, estimated mean body weight change was −16.0% with semaglutide versus −5.7% with placebo, a difference of 10.3 percentage points (95% CI −12.0 to −8.6). More participants on semaglutide lost at least 5% of baseline weight (86.6% versus 47.6%), at least 10% (75.3% versus 27.0%) and at least 15% (55.8% versus 13.2%).

The trial completed 92.8% of randomised participants, with 82.7% still receiving treatment at trial end. That retention is itself relevant, because adherence is the mechanism through which coaching plausibly acts.

Reading the Comparison Honestly

The placebo arm is the cleanest estimate of what intensive behavioral therapy achieved on its own in this population: −5.7% over 68 weeks, roughly double the −2.4% seen in the STEP 1 placebo arm, which received lifestyle counselling rather than 30 structured visits.

The semaglutide arm result of −16.0% is close to the −14.9% reported in STEP 1 with less intensive support. That comparison is across trials rather than within one, so it does not establish that coaching adds a specific increment on top of the medication.

What it does establish is that both components have measurable effects and that the medication effect is the larger one. Neither substitutes for the other, and both weight-management indications are written as adjuncts to a reduced-calorie diet and increased physical activity for exactly this reason.

Where Coaching Plausibly Does the Most Work

Adherence and persistence. A substantial share of people who start a GLP-1 receptor agonist stop within a year, and randomised withdrawal trials across the class consistently show substantial weight regain after discontinuation. Anything that keeps someone engaged through the early adverse-reaction period changes outcomes.

Nutritional adequacy. Appetite suppression reduces total intake, and micronutrient and protein intake tend to fall with it. Structured support makes it likelier that protein targets and resistance training happen rather than being intended.

Symptom navigation. Gastrointestinal adverse events were more frequent with semaglutide in STEP 3 (82.8% versus 63.2%), and 3.4% of semaglutide participants discontinued because of them. Knowing what to report and when is part of staying on therapy safely.

What Coaching Cannot Do

It cannot make dosage decisions. Escalation, holding and stepping back are prescriber judgements informed by tolerability and your full clinical picture, and the FDA has documented adverse events associated with dosing beyond approved labels.

It cannot screen for contraindications. A personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 is a labeled contraindication for both semaglutide and tirzepatide products, and that assessment is clinical.

And it cannot replace medical follow-up for adverse reactions. Persistent vomiting, severe abdominal pain or signs of volume depletion go to a clinician, not to a coach.

What "Coaching" Means Varies Enormously

STEP 3 used 30 counselling visits with trained personnel over 68 weeks. That is a specific, resource-intensive intervention, and it is not what most commercial programmes deliver.

A weekly app notification, a monthly group call and a registered dietitian consultation are three very different things. When evaluating a programme, the useful questions are who delivers it, what their qualifications are, how often contact occurs and what specifically is covered.

Registered dietitian involvement is the component with the clearest professional standard attached, and referral is a normal part of care in this setting rather than an upsell.

Building a Realistic Plan

Assume the horizon is a year or more, because that is the timeframe over which the evidence was generated. Plan the funding route before starting, because an interruption behaves like a deliberate stop.

Track more than weight: blood pressure, glycemic markers where relevant, symptom burden, nutritional adequacy and physical function. Several of the outcome benefits in this class are not visible on a scale.

And keep the medication decisions where they belong. The most useful coaching arrangement is one that strengthens adherence and nutrition while routing clinical questions promptly to the prescriber.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Does behavioral coaching actually improve GLP-1 results?

STEP 3 provides the closest evidence. Every participant received intensive behavioral therapy — 30 counselling visits over 68 weeks plus an initial low-calorie diet — and the placebo arm lost a mean 5.7% of body weight, roughly double the 2.4% seen in STEP 1's placebo arm with standard counselling. The semaglutide arm lost 16.0%, a difference of 10.3 percentage points.

Is the medication or the coaching doing the work?

Both, with the medication contributing more. In STEP 3 the between-group difference was 10.3 percentage points at 68 weeks, while the coaching-alone arm achieved −5.7%. Both weight-management indications are written as adjuncts to a reduced-calorie diet and increased physical activity, because every pivotal trial delivered the medication on top of a lifestyle intervention.

How intensive does support need to be?

STEP 3 used 30 counselling visits over 68 weeks with trained personnel, which is considerably more than most commercial programmes deliver. When evaluating a programme, ask who delivers it, what qualifications they hold, how often contact occurs and what is covered. Registered dietitian involvement carries the clearest professional standard.

Can a coach help with side effects?

Only by helping you recognise what to report and when. Gastrointestinal adverse events were more frequent with semaglutide in STEP 3 (82.8% versus 63.2%), and 3.4% of semaglutide participants discontinued because of them. Persistent vomiting, severe abdominal pain or signs of volume depletion require a clinician, not a coach, and dosage decisions belong to your prescriber.

What should coaching focus on during treatment?

Adherence through the early adverse-reaction period, protein adequacy and resistance training to preserve lean mass as total intake falls, sleep, and building habits that survive the maintenance phase. Randomised withdrawal trials across this class consistently show substantial regain after discontinuation, so persistence is the outcome that matters most.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.